{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T05:10:49Z","timestamp":1790745049254,"version":"4.1.0"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"University of Miyazaki Hospital"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0225586","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T13:30:34Z","timestamp":1574688634000},"page":"e0225586","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Upregulation of ERK phosphorylation in rat dorsal root ganglion neurons contributes to oxaliplatin-induced chronic neuropathic pain"],"prefix":"10.1371","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2660-2179","authenticated-orcid":true,"given":"Toyoaki","family":"Maruta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutaro","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Koshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Shirasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Yanagita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryu","family":"Takeya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Tsuneyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"issue":"2","key":"pone.0225586.ref001","first-page":"13","article-title":"Pharmacokinetics and safety profile of oxaliplatin","volume":"25","author":"JM Extra","year":"1998","journal-title":"Semin Oncol"},{"key":"pone.0225586.ref002","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mus.10559","article-title":"Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy","volume":"29","author":"TJ Lehky","year":"2004","journal-title":"Muscle Nerve"},{"key":"pone.0225586.ref003","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1474-4422(10)70143-5","article-title":"Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment","volume":"9","author":"R Baron","year":"2010","journal-title":"Lancet Neurol"},{"key":"pone.0225586.ref004","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00415-017-8641-6","article-title":"Advances in understanding nociception and neuropathic pain","volume":"265","author":"E St John Smith","year":"2018","journal-title":"J Neurol"},{"key":"pone.0225586.ref005","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1152\/jn.2001.85.5.2293","article-title":"A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels","volume":"85","author":"F Grolleau","year":"2001","journal-title":"J Neurophysiol"},{"key":"pone.0225586.ref006","doi-asserted-by":"crossref","first-page":"6704","DOI":"10.1073\/pnas.1118058109","article-title":"Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current","volume":"109","author":"R Sittl","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0225586.ref007","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/j.pain.2013.05.032","article-title":"An animal model of oxaliplatin-induced cold allodynia reveals a crucial role for Nav1.6 in peripheral pain pathways","volume":"154","author":"JR Deuis","year":"2013","journal-title":"Pain"},{"key":"pone.0225586.ref008","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neulet.2009.04.029","article-title":"Involvement of increased expression of transient receptor potential melastatin 8 in oxaliplatin-induced cold allodynia in mice","volume":"458","author":"P Gauchan","year":"2009","journal-title":"Neurosci Lett"},{"key":"pone.0225586.ref009","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.pain.2011.02.051","article-title":"Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation","volume":"152","author":"R Nassini","year":"2011","journal-title":"Pain"},{"key":"pone.0225586.ref010","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/emmm.201100134","article-title":"Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors","volume":"3","author":"J Descoeur","year":"2011","journal-title":"EMBO Mol Med"},{"key":"pone.0225586.ref011","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/brb3.34","article-title":"Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation","volume":"2","author":"T Kono","year":"2012","journal-title":"Brain Behav"},{"key":"pone.0225586.ref012","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.lfs.2004.01.007","article-title":"MAPK activation in nociceptive neurons and pain hypersensitivity","volume":"74","author":"K Obata","year":"2004","journal-title":"Life Sci"},{"key":"pone.0225586.ref013","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.brainresrev.2008.12.011","article-title":"MAP kinase and pain","volume":"60","author":"RR Ji","year":"2009","journal-title":"Brain Res Rev"},{"key":"pone.0225586.ref014","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.neuro.2009.01.003","article-title":"Role of MAPKs in platinum-induced neuronal apoptosis","volume":"30","author":"A Scuteri","year":"2009","journal-title":"Neurotoxicology"},{"key":"pone.0225586.ref015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neulet.2010.09.028","article-title":"NGF protects dorsal root ganglion neurons from oxaliplatin by modulating JNK\/Sapk and ERK1\/2","volume":"486","author":"A Scuteri","year":"2010","journal-title":"Neurosci Lett"},{"key":"pone.0225586.ref016","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ejpain.2010.08.006","article-title":"Prevention of oxaliplatin-induced mechanical allodynia and neurodegeneration by neurotropin in the rat model","volume":"15","author":"T Kawashiri","year":"2011","journal-title":"Eur J Pain"},{"key":"pone.0225586.ref017","first-page":"39","article-title":"Monosodium iodoacetate-induced joint pain is associated with increased phosphorylation of mitogen activated protein kinases in the rat spinal cord","volume":"7","author":"Y Lee","year":"2011","journal-title":"Mol Pain"},{"key":"pone.0225586.ref018","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1744-8069-7-12","article-title":"Mechanisms involved in extraterritorial facial pain following cervical spinal nerve injury in rats","volume":"7","author":"A Kobayashi","year":"2011","journal-title":"Mol Pain"},{"key":"pone.0225586.ref019","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1213\/ANE.0b013e3181e9f62f","article-title":"The effect of pulsed radiofrequency current on mechanical allodynia induced with resiniferatoxin in rats","volume":"111","author":"N Tanaka","year":"2010","journal-title":"Anesth Analg"},{"key":"pone.0225586.ref020","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"NIH Image to ImageJ: 25 years of image analysis","volume":"9","author":"CA Schneider","year":"2012","journal-title":"Nat Methods"},{"key":"pone.0225586.ref021","doi-asserted-by":"crossref","first-page":"523","DOI":"10.2174\/157015911798376208","article-title":"Role of neurotrophins in neuropathic pain","volume":"9","author":"D Siniscalco","year":"2011","journal-title":"Curr Neuropharmacol"},{"key":"pone.0225586.ref022","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/ijc.29367","article-title":"PKC\/MEK inhibitors suppress oxaliplatin-induced neuropathy and potentiate the antitumor effects","volume":"137","author":"M Tsubaki","year":"2015","journal-title":"Int J Cancer"},{"key":"pone.0225586.ref023","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1002\/ijc.29980","article-title":"Clonidine, an alpha-2 adrenoceptor agonist relieves mechanical allodynia in oxaliplatin-induced neuropathic mice; potentiation by spinal p38 MAPK inhibition without motor dysfunction and hypotension","volume":"138","author":"JH Yeo","year":"2016","journal-title":"Int J Cancer"},{"key":"pone.0225586.ref024","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/mus.10559","article-title":"Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy","volume":"29","author":"TJ Lehky","year":"2004","journal-title":"Muscle Nerve"},{"key":"pone.0225586.ref025","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1200\/JCO.2008.19.3425","article-title":"Acute abnormalities of sensory nerve function associated with oxaliplatin-induced neurotoxicity","volume":"27","author":"SB Park","year":"2009","journal-title":"J Clin Oncol"},{"key":"pone.0225586.ref026","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-2999(00)00667-1","article-title":"The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons","volume":"40","author":"H Adelsberger","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"pone.0225586.ref027","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1038\/sj.bjp.0706407","article-title":"Oxaliplatin induces hyperexcitability at motor and autonomic neuromuscular junctions through effects on voltage-gated sodium channels","volume":"146","author":"RG Webster","year":"2005","journal-title":"Br J Pharmacol"},{"key":"pone.0225586.ref028","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.neuro.2008.09.005","article-title":"The effects of oxaliplatin, an anticancer drug, on potassium channels of the peripheral myelinated nerve fibres of the adult rat","volume":"29","author":"A Kagiava","year":"2008","journal-title":"Neurotoxicology"},{"key":"pone.0225586.ref029","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.neuro.2010.07.006","article-title":"Enhancement of axonal potassium conductance reduces nerve hyperexcitability in an in vitro model of oxaliplatin-induced acute neuropathy","volume":"31","author":"R Sittl","year":"2010","journal-title":"Neurotoxicology"},{"key":"pone.0225586.ref030","first-page":"263","article-title":"Oxaliplatin an anticancer agent that affects both Na+ and K+ channels in frog peripheral myelinated axons","volume":"25","author":"E Benoit","year":"2006","journal-title":"Gen Physiol Biophys"},{"key":"pone.0225586.ref031","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.neuro.2009.04.010","article-title":"The mechanism of the actions of oxaliplatin on ion currents and action potentials in differentiated NG108-15 neuronal cells","volume":"30","author":"SN Wu","year":"2009","journal-title":"Neurotoxicology"},{"key":"pone.0225586.ref032","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.celrep.2013.12.033","article-title":"Pain without nociceptors? Nav1.7-independent pain mechanisms","volume":"6","author":"MS Minett","year":"2014","journal-title":"Cell Rep"},{"key":"pone.0225586.ref033","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.neuropharm.2019.04.024","article-title":"MiR-30b-5p attenuates oxaliplatin-induced peripheral neuropathic pain through the voltage-gated sodium channel Nav1.6 in rats","volume":"153","author":"L Li","year":"2019","journal-title":"Neuropharmacology"},{"key":"pone.0225586.ref034","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s10753-017-0645-y","article-title":"Melatonin Attenuates Pain Hypersensitivity and Decreases Astrocyte-Mediated Spinal Neuroinflammation in a Rat Model of Oxaliplatin-Induced Pain","volume":"40","author":"YS Wang","year":"2017","journal-title":"Inflammation"},{"key":"pone.0225586.ref035","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1097\/j.pain.0000000000001212","article-title":"Chemokine CCL2 and its receptor CCR2 in the dorsal root ganglion contribute to oxaliplatin-induced mechanical hypersensitivity","volume":"159","author":"AM Illias","year":"2018","journal-title":"Pain"},{"key":"pone.0225586.ref036","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.2174\/1871520618666180525091158","article-title":"Oxaliplatin regulates chemotherapy induced peripheral neuropathic pain in the dorsal horn and dorsal root ganglion via the calcineurin\/NFAT Pathway","volume":"18","author":"W Huang","year":"2018","journal-title":"Anticancer Agents Med Chem"},{"key":"pone.0225586.ref037","doi-asserted-by":"crossref","first-page":"1744806917726256","DOI":"10.1177\/1744806917726256","article-title":"Upregulation of CX3CL1 mediated by NF-\u03baB activation in dorsal root ganglion contributes to peripheral sensitization and chronic pain induced by oxaliplatin administration","volume":"13","author":"J Wang","year":"2017","journal-title":"Mol Pain"},{"key":"pone.0225586.ref038","doi-asserted-by":"crossref","first-page":"1744806918769426","DOI":"10.1177\/1744806918769426","article-title":"Involvement of pro-inflammation signal pathway in inhibitory effects of rapamycin on oxaliplatin-induced neuropathic pain","volume":"14","author":"Z Duan","year":"2018","journal-title":"Mol Pain"},{"key":"pone.0225586.ref039","first-page":"1744806918783535","article-title":"Participation of pro-inflammatory cytokines in neuropathic pain evoked by chemotherapeutic oxaliplatin via central GABAergic pathway","volume":"14","author":"D Xu","year":"2018","journal-title":"Mol Pain"},{"key":"pone.0225586.ref040","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1097\/ALN.0000000000001010","article-title":"Resolvin D1 Inhibits Mechanical Hypersensitivity in Sciatica by Modulating the Expression of Nuclear Factor-\u03baB, Phospho-extracellular Signal-regulated Kinase, and Pro- and Anti-inflammatory Cytokines in the Spinal Cord and Dorsal Root Ganglion","volume":"124","author":"ZH Liu","year":"2016","journal-title":"Anesthesiology"},{"key":"pone.0225586.ref041","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1523\/JNEUROSCI.3858-05.2006","article-title":"Acute p38-mediated modulation of tetrodotoxin-resistant sodium channels in mouse sensory neurons by tumor necrosis factor-\u03b1","volume":"26","author":"X Jin","year":"2006","journal-title":"J Neurosci"},{"key":"pone.0225586.ref042","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.expneurol.2006.11.016","article-title":"p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury","volume":"204","author":"JT Xu","year":"2007","journal-title":"Exp Neurol"},{"key":"pone.0225586.ref043","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1523\/JNEUROSCI.4872-09.2010","article-title":"ERK1\/2 mitogen-activated protein kinase phosphorylates sodium channel Na(v)1.7 and alters its gating properties","volume":"30","author":"S Stamboulian","year":"2010","journal-title":"J Neurosci"},{"key":"pone.0225586.ref044","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejphar.2010.04.048","article-title":"NaV1.7-Ca2+ influx-induced increased phosphorylations of extracellular signal-regulated kinase (ERK) and p38 attenuate tau phosphorylation via glycogen synthase kinase-3\u03b2: priming of NaV1.7 gating by ERK and p38","volume":"640","author":"T Nemoto","year":"2010","journal-title":"Eur J Pharmacol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225586","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T13:30:52Z","timestamp":1574688652000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0225586"}},"subtitle":[],"editor":[{"given":"Ferenc","family":"Gallyas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":44,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2019,11,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0225586","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,25]]}}}